...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: The slow bleed on low volume continues.....

I am merely pointing out the risks here, which are very real.....nobody, certainly not I, has a crystal ball. RVX will be doing a futility evaluation at about the midway point....and we shall see what the steering group has to say at that point, whether they recommend continuing with the trial or ending it. Both are legitimate possibilities.

Share
New Message
Please login to post a reply